iTeos Therapeutics SA Files Patent for Immunomodulators in Cancer Immunotherapy
Gosselies, Belgium (ots/PRNewswire) - iTeos Therapeutics SA today announced the filing of the Company's first patent applications protecting proprietary inhibitors of the intracellular enzyme TDO2, which is expressed at high levels in specific cancers. iTeos Therapeutics has collaborated with Ludwig Cancer Research over the last year to identify small molecule ...
mehr